Related references
Note: Only part of the references are listed.Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
Wungki Park et al.
CLINICAL CANCER RESEARCH (2020)
Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigens
Paula Jaime-Sanchez et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Allogenic V9V2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Dual Role of Lanthanum Oxide Nanoparticles Functionalized Co-Polymeric Micelle for Extended Anti-Cancer Drug Delivery
Kandasamy Vinothini et al.
CHEMISTRYSELECT (2019)
Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
Wei-Di Yu et al.
CANCER LETTERS (2019)
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
Crystal A. Tonnessen-Murray et al.
JOURNAL OF CELL BIOLOGY (2019)
Selenium nanoparticles as new strategy to potentiate γδ T cell anti-tumor cytotoxicity through upregulation of tubulin-α acetylation
Yi Hu et al.
BIOMATERIALS (2019)
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
Milica Momcilovic et al.
NATURE (2019)
Polymethyl methacrylate-ovalbumin @ graphene oxide drug carrier system for high anti-proliferative cancer drug delivery
Selvakani Prabakaran et al.
APPLIED NANOSCIENCE (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
Chimeric antigen receptor T-cell therapies for lymphoma
Jennifer N. Brudno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Junjie Wu et al.
CANCER LETTERS (2018)
The Good, the Bad, and the Ugly of ROS: New Insights on Aging and Aging-Related Diseases from Eukaryotic and Prokaryotic Model Organisms
Ana L. Santos et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Mitochondrial metabolism and cancer
Paolo Ettore Porporato et al.
CELL RESEARCH (2018)
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Seema Kumari et al.
BIOMARKER INSIGHTS (2018)
A Milestone for CAR T Cells
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities
Zheng Xiang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combination immunotherapy: a road map
Patrick A. Ott et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The Central Role of Amino Acids in Cancer Redox Homeostasis: vulnerability Points of the Cancer Redox Code
Milica Vucetic et al.
FRONTIERS IN ONCOLOGY (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Poly-carboxylic acids functionalized chitosan nanocarriers for controlled and targeted anti-cancer drug delivery
Mariappan Rajan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
Yuval Shaked
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Surface functionalization of natural lignin isolated from Aloe barbadensis Miller biomass by atom transfer radical polymerization for enhanced anticancer efficacy
Murugaraj Jeyaraj et al.
RSC ADVANCES (2016)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Mitochondrial membrane potential and reactive oxygen species in cancer stem cells
Bei-bei Zhang et al.
FAMILIAL CANCER (2015)
AFM resolves effects of ethambutol on nanomechanics and nanostructures of single dividing mycobacteria in real-time
Yangzhe Wu et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Human V2V2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors
Reeva Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo
Ismahene Benzaid et al.
CANCER RESEARCH (2011)
BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: An AFM and Raman microspectroscopy study
Yangzhe Wu et al.
CANCER LETTERS (2010)
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
S. Meraviglia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
In situ, real-time tracking of cell wall topography and nanomechanics of antimycobacterial drugs treated Mycobacterium JLS using atomic force microscopy
Yangzhe Wu et al.
CHEMICAL COMMUNICATIONS (2009)
Time-dependent surface adhesive force and morphology of RBC measured by AFM
Yangzhe Wu et al.
MICRON (2009)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
The Analysis of Morphological Distortion During AFM Study of Cells
Yangzhe Wu et al.
SCANNING (2008)
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
Stephen R. Mattarollo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Share Paper
